Stay updated with breaking news from Gerard evan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Omega Therapeutics Announces Promising Preliminary Clinical Data for OTX-2002 from Ongoing MYCHELANGELO™ I Trial streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
CAMBRIDGE, Mass., Sept. 25, 2023 Omega Therapeutics, Inc. , a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines, today. ....
Omega Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data for OTX-2002 from Ongoing MYCHELANGELO™ I Trial on September 26 itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.
Professor Doreen Cantrell, Wellcome Trust Principal Research Fellow at the University of Dundee’s School of Life Sciences, has been appointed as one of two new trustees of Cancer Research UK one of the world’s biggest cancer charities. Click to read more. ....
Vincerx Pharma Announces Formation of Scientific Advisory Board to Advance its Clinical Pipeline News Provided By Share This Article /EIN News/ PALO ALTO, Calif., April 01, 2021 (GLOBE NEWSWIRE) Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced the formation of its Scientific Advisory Board (SAB) composed of world leading academics and industry leaders in cancer research and therapeutics. John C. Byrd, M.D., will serve as Chairman of the SAB. “The Vincerx team is thrilled to welcome globally recognized key opinion leaders in hematologic malignancies and oncology drug development to our newly formed SAB,” said Ahmed Hamdy M.D., Chief Executive Officer of Vincerx. “Their collective expertise aligns with the advancement of our diversified oncology pipeline and will be critical as we expand our research and developmen ....